Search U.S. Product Recalls Database

Showing 101–120 of 29086 results

Sort:

Prazosin Hydrochloride 2mg Capsules (Amerisource) – Impurity Risk (2025)

Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit

Class IIModerate

FDAOct 16, 2025Nationwide• Amerisource Health Services LLC

Cinnamon Whiskey Pecans (Nats Nuts) - Undeclared Cashews (2025)

Undeclared Allergen

Contains undeclared cashews

Class IIModerate

FDAOct 16, 2025CT, FL, NV +6 more• Nats Nuts LLC

Stay Informed

Search Product Recalls

Prazosin Hydrochloride 2mg Capsules (Amerisource) – Impurity Risk (2025)

Cinnamon Whiskey Pecans (Nats Nuts) - Undeclared Cashews (2025)

Prazosin Hydrochloride 5mg Capsules (Amerisource) – Impurity Risk (2025)

Prazosin Hydrochloride 1mg Capsules (Amerisource) – Impurity Risk (2025)

Semaglutide 12.5mg Injection (ProRx) – Sterility Concern (2025)

Semaglutide 6mg Injection (ProRx) – Sterility Concern (2025)

Semaglutide 8mg Injection (ProRx) – Sterility Concern (2025)

Semaglutide 10mg Injection (ProRx) – Sterility Concern (2025)

Semaglutide 2.5mg Injection (ProRx) – Sterility Concern (2025)

Tirzepatide 27mg Injection (ProRx) – Sterility Concern (2025)

Semaglutide 5mg Injection (ProRx) – Sterility Concern (2025)

Testosterone Triamcinolone Pellet (Farmakeio) – Metal Contamination (2025)

Testosterone Triamcinolone Pellet (Farmakeio) – metal particulate risk (2025)

Testosterone Release Pellet (Farmakeio) – metal particulate risk (2025)

Testosterone Triamcinolone Pellet (Farmakeio) – metal particulate risk (2025)

Testosterone Triamcinolone Pellet (Farmakeio) – metal particulate risk (2025)

Testosterone Triamcinolone Pellet (Farmakeio) – Metal Contamination (2025)

Testosterone Triamcinolone Pellet (Farmakeio) – metal particulate risk (2025)

Testosterone Release Pellet (Farmakeio) – metal particulate risk (2025)

Testosterone 50mg Pellet (Farmakeio) – Metal Contamination (2025)